Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06323109 · ClinicalTrials.gov registry record
US Imaging for the Assessment of LUTS
A clinical trial of Lower Urinary Tract Symptoms and BPH, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT06323109: Recruiting study of Lower Urinary Tract Symptoms and BPH, sponsored by University of Wisconsin, Madison.
NCT06323109 is a study of Lower Urinary Tract Symptoms and BPH that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 80 participants, below the 747-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06323109, a study of Lower Urinary Tract Symptoms and BPH, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to develop an ultrasound (US) based urodynamics (UDS) evaluation of voiding based on successful magnetic resonance imaging (MRI)-UDS evaluation. Both US and MRI are non-invasive imaging techniques, but US is a more cost-effective and widely available technology. 80 participants will be enrolled and will be on study for up to 2.5 hours (1.5 hour MRI and 1 hour US).
Primary Outcome
MRI-based CFD technique (MRI - UDS) provides voiding flow rates and bladder pressures which can be used to calculate the widely used metrics of obstruction (bladder outlet obstruction index, BOOI) and contractility (bladder contractility index, BCI). Bladder volumes are quantified from the time resolved volumetric data acquired during the void event in each patient. The outcomes from the MRI based CFD simulations of the voiding event are urine velocity and pressure in the bladder and urethra a
Conditions Studied
Interventions
- DEVICE MRI-UDS; US-UDS; MCUD
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-11-28 |
| Est. Completion | 2027-01 |
What NCT06323109 shows while recruiting
NCT06323109 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 747-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Lower Urinary Tract Symptoms appearing as the primary indexed condition, and to 1 intervention - of which MRI-UDS; US-UDS; MCUD is the first listed.
NCT06323109 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06323109 about?
NCT06323109 is a clinical study titled "US Imaging for the Assessment of LUTS". The purpose of this research is to develop an ultrasound (US) based urodynamics (UDS) evaluation of voiding based on successful magnetic resonance imaging (MRI)-UDS evaluation. Both US and MRI are non-invasive imaging techniques, but US is a more cost-effective and widely available technology. 80 pa...
What is the current status of trial NCT06323109?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2023-11-28. Estimated completion is 2027-01.
What conditions does trial NCT06323109 study?
This clinical trial studies the following conditions: Lower Urinary Tract Symptoms, BPH.
What interventions are being tested in trial NCT06323109?
The interventions under investigation include: MRI-UDS; US-UDS; MCUD (DEVICE).
Who is sponsoring clinical trial NCT06323109?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06323109 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Urinary Tract Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06323109's enrollment target sits among peer trials
80 12th of 21 higher than 10 of 21 other Lower Urinary Tract Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lower Urinary Tract Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
RECRUITING · Phase 2
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
-
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
BPH Global Registry
RECRUITING
-
PRescription Exercise for Older Men With Urinary Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI